drugset / Trial / NCT01265342

Efficacy of Nebulised Beclometasone in Viral Wheezing Prophylaxis

NCT01265342

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Inhaled steroids, in particular beclomethasone, are widely prescribed in Italy as symptomatic treatment of upper respiratory infections without evidence of efficacy. The purpose of this study is to evaluate the efficacy of beclomethasone (administered by nebuliser twice a day) in preventing viral wheezing in pre-school children who had had episodes in the preceding 12 months.

Timeline

Start
2010-10
Primary completion
2012-03
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Beclomethasone Small molecule 400 ug